The Biden administration is encouraging states with low vaccination rates and surging hospitalizations to offer monoclonal antibody treatment to people who have early-stage Covid-19, according to a New York Times report.
The drug treatment, which has emergency use authorization, was used to treat Donald Trump when he was president and got sick with Covid-19. It helps prevent the progression of the virus, potentially protecting people from hospitalization and death, experts say.
The Times reported, "Distribution of doses, which are ordered by medical providers, increased fivefold from June to July. About 75 percent of the ordering is from regions of the country with low vaccination rates, according to the Department of Health and Human Services."
Dr. Marcella Nunez-Smith, a White House adviser on racial equity in health, added that vaccination is still the best option.
At www.nytimes.com
